These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
29. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758 [TBL] [Abstract][Full Text] [Related]
30. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
31. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation. Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190 [TBL] [Abstract][Full Text] [Related]
32. Allograft vasculopathy in cardiac transplant recipients: an early experience. Trivedi S; Mullasari AS; Arumugam SB; Cherian KM Indian Heart J; 1999; 51(5):548-50. PubMed ID: 10721649 [No Abstract] [Full Text] [Related]
35. Suppressive effects of combination therapy with mizoribine and FK 506 on the development of accelerated coronary artery disease and myocardial rejection after heart transplantation. Ogawa N; Koyama I; Shibata T; Watanabe T; Akimoto N; Taguchi Y; Shinozuka N; Omoto R Transplant Proc; 1996 Jun; 28(3):1394-6. PubMed ID: 8658710 [No Abstract] [Full Text] [Related]
36. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
37. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation. Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119 [TBL] [Abstract][Full Text] [Related]
38. Impact of ethnicity, donor status and HLA matching on renal allograft survival: a single center study. Chelluri LK; Vasantha A; Ratnakar KS Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):995-7. PubMed ID: 19861859 [TBL] [Abstract][Full Text] [Related]
39. Immunology of pediatric heart transplantation: a clinical update. Webber SA Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():158-84. PubMed ID: 11460982 [TBL] [Abstract][Full Text] [Related]